Statement Of Changes In Equity [Abstract]

Ascelia Pharma - Filing #678716

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through exercise of warrants, equity
- SEK
- SEK
- SEK
- SEK
- SEK
- SEK
- SEK
- SEK
- SEK
- SEK
- SEK
- SEK
- SEK
- SEK
Increase (decrease) through transactions with owners, equity
- SEK
- SEK
3 058 SEK
- SEK
3 058 SEK
3 058 SEK
- SEK
3 529 SEK
295,000 SEK
3 529 SEK
3 317 SEK
- SEK
- SEK
84,000 SEK
Share issue related cost
- SEK
- SEK
30,000 SEK
- SEK
30,000 SEK
30,000 SEK
- SEK
84,000 SEK
- SEK
84,000 SEK
- SEK
- SEK
- SEK
84,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.